Zobrazeno 1 - 10
of 392
pro vyhledávání: ''
Autor:
Chrysoula Koumanidou, Maria Papadaki, Antonios Marmarinos, Achilleas Attilakos, Eftymia Alexopoulou, Marina Vakaki, Dimitrios Gourgiotis, Anastasia Garoufi, Georgios Karapostolakis
Publikováno v:
Angiology. 72:322-331
Carotid intima-media thickness (cIMT) has been proposed as an early marker of subclinical atherosclerosis in high risk children. Children with heterozygous familial hypercholesterolemia have greater cIMT than matched healthy controls or their unaffec
Publikováno v:
Angiology. 71:609-615
The clinical outcomes of nicorandil in percutaneous coronary intervention (PCI) are conflicting. We sought to evaluate the effects of nicorandil on periprocedural myocardial injury (PMI) in elective PCI. Eligible studies that reported the effect of n
Autor:
A Lian Zhang, Chao Xue, Chang Qian Wang, Ling Bian, Zuo Jun Xu, Yu Shui Xie, Qi Zhi Chen, Hui Li Zhang, Zhao Fang Yin, Run Du
Publikováno v:
Angiology. 70:719-725
The effects of nicotine replacement therapy (NRT)-aided smoking cessation on vascular function are not fully clarified. We investigated 100 healthy smokers who were motivated to quit and received NRT for a 3-month period. Vascular endothelial functio
Publikováno v:
Angiology. 70:305-316
Contrast-induced acute kidney injury (CI-AKI) is a common complication of iodinated contrast medium administration during cardiac catheterization. Statin treatment has been shown to be associated with reduced risk of CI-AKI; however, the results are
Autor:
Alan A. Sag, Mehmet Kanbay, Onur Yilmaz, Dimitrie Siriopol, Adrian Covic, Baris Afsar, Nihan Erden, Patrick Rossignol, Masanari Kuwabara, Neris Dincer, Alberto Ortiz, David Z.I. Cherney
Publikováno v:
Angiology. 71(4)
Several trials have been completed in patients with heart failure (HF) treated with uric acid (UA)-lowering agents with inconsistent results. We aimed to investigate whether lowering UA would have an effect on mortality and cardiovascular (CV) events
Publikováno v:
Angiology. 70:62-68
Coronary artery ectasia (CAE) is a rare disease and a substantial portion of patients with CAE are first diagnosed with acute myocardial infarction (AMI). The question was raised if CAE was a kind of thrombotic disease. We assessed a consecutive seri
Autor:
Sofia Giannitsi, Athanasios J. Manolis, Manolis S. Kallistratos, Pavlos Tsinivizov, Leonidas E. Poulimenos
Publikováno v:
Angiology. 70:291-298
Trimetazidine (TMZ) is a metabolic agent with significant anti-ischemic properties. By inhibiting the terminal enzyme in the β-oxidation pathway, it shifts the energy substrate metabolism, enhancing glucose metabolism. Thus, it maintains the require
Autor:
Mauro Pennacchi, Gualtiero Palareti, Giuseppe Patti, Emilia Antonucci, Plinio Cirillo, Rossella Marcucci, Vittorio Pengo, for Eyeshot Study, Paolo Calabrò, Leonardo De Luca, Marco Di Maio, Felice Gragnano, Antonino Granatelli, Start Antiplatelet Register, Pasquale Pignatelli, Paolo Gresele, Stefano De Servi
Publikováno v:
Angiology. 69:795-802
The epidemiology and management of patients with acute coronary syndromes (ACSs) have evolved. We aimed to describe recent demographics and therapeutic changes in the Italian ACS population. We analyzed data from 2 multicenter consecutive Italian reg
Autor:
Thomas Gremmel, Renate Koppensteiner, Patricia P. Wadowski, Christoph W. Kopp, Simon Panzer, Silvia Lee
Publikováno v:
Angiology. 69:786-794
Low high-density lipoprotein cholesterol (HDL-C) levels are an independent predictor of ischemic events in patients with atherosclerotic cardiovascular disease. This may in part be due to decreased clopidogrel-mediated platelet inhibition in patients
Publikováno v:
Angiology. 69:724-729
The aim of this study was to examine the relationship between low-density lipoprotein cholesterol (LDL-C) and apolipoprotein (Apo) B levels and the SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score (SS)